PROLACTINOMA
Clinical trials for PROLACTINOMA explained in plain language.
Never miss a new study
Get alerted when new PROLACTINOMA trials appear
Sign up with your email to follow new studies for PROLACTINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a 6-Month drug course cure pituitary tumors?
⭐️ CURE ⭐️ Recruiting nowThis study tests whether a high dose of the drug cabergoline given for about 6 months can cure small pituitary tumors (microprolactinomas) in women. Currently, standard treatment uses the lowest effective dose for 2 years. The goal is to see if the short high-dose approach leads …
Matched conditions: PROLACTINOMA
Phase: PHASE3 • Sponsor: University of Sao Paulo General Hospital • Aim: ⭐️ CURE ⭐️
Last updated May 13, 2026 15:59 UTC
-
Prolactinoma drug study: which strategy protects your metabolism?
Disease control Recruiting nowThis study looks at how two different ways of using dopamine agonists (standard medicines for prolactinoma) affect the body's ability to handle sugar. About 60 adults with prolactinoma will take one of two treatment plans and then take a glucose drink test to measure blood sugar …
Matched conditions: PROLACTINOMA
Phase: PHASE4 • Sponsor: University Hospital, Basel, Switzerland • Aim: Disease control
Last updated May 17, 2026 07:03 UTC
-
Estrogen exposure may determine pituitary tumor size in women
Knowledge-focused Recruiting nowThis study looks at whether women who had more estrogen exposure (from birth control, hormone therapy, pregnancy, or early puberty) are more likely to develop large prolactin-secreting pituitary tumors instead of small ones. Researchers will compare the estrogen histories of 180 …
Matched conditions: PROLACTINOMA
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated May 17, 2026 06:48 UTC
-
Scientists hunt for genetic clues behind childhood pituitary tumors
Knowledge-focused Recruiting nowThis study looks at children with pituitary or hypothalamic tumors to find genetic causes and improve diagnosis. Researchers will collect blood and tumor samples for genetic testing and test new MRI techniques. Up to 2000 participants are needed. The goal is to learn more about t…
Matched conditions: PROLACTINOMA
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) • Aim: Knowledge-focused
Last updated May 11, 2026 20:52 UTC